Abstract: Objective To investigate the diagnostic value of alpha fetoprotein (AFP), alphafetoprotein-
L-3 ratio (AFP-L3%) and golgi protein 73 (GP73) on hepatitis B-related primary
liver cancer (PLC). Method A total of 182 patients with hepatitis B virus infection who were
admitted to the outpatient and inpatient department of the Department of Infectious Diseases,
Second Affiliated Hospital of Anhui Medical University from January 2018 to July 2023
were selected. Among them, there were 60 patients with primary liver cancer (PLC group),
85 patients with liver cirrhosis (liver cirrhosis group) and 37 patients with chronic hepatitis
B (CHB group). Serum AFP, AFP-L3%, and GP73 levels of patients in each group were
detected. Receiver operating characteristic (ROC) curve was used to evaluate the diagnostic
value of AFP, AFP-L3%, GP73 and combined detection on PLC. Results The levels of AFP
(median: 116 μg/L vs. 5.32 μg/L vs. 5.08 μg/L) and AFP-L3% (median:5.23 μg/L vs. 0 μg/L vs. 0 μg/L)
of patients in liver cancer group were significantly higher than those of liver cirrhosis group
and CHB group (all P < 0.05), while there was no statistically significant difference in GP73
levels among the three groups (median: 84.09 μg/L vs. 95.22 μg/L vs. 64.57 μg/L; H = 1.52,
P = 0.47). The area under the ROC curve for diagnosing PLC of AFP, AFP-L3%, GP73, AFP +
AFP-L3% and AFP + AFP-L3% + GP73 were 0.79, 0.78, 0.49, 0.83 and 0.81, respectively.
The combined detection of the three indicators had the highest specificity (89.10%) and
total effective rate (81.82%). Conclusions AFP and AFP-L3% had good diagnostic value
as auxiliary diagnostic indicators on PLC, while GP73 had relatively low diagnostic value.
The combined detection of AFP, AFP-L3% and GP73 could improve the specificity of PLC
diagnosis and had high clinical value for the diagnosis of PLC.
|